BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 32901590)

  • 1. Role of Inflammation in the Development of Colorectal Cancer.
    Muthusami S; Ramachandran IK; Babu KN; Krishnamoorthy S; Guruswamy A; Queimado L; Chaudhuri G; Ramachandran I
    Endocr Metab Immune Disord Drug Targets; 2021; 21(1):77-90. PubMed ID: 32901590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of MicroRNAs in Inflammation-Associated Colorectal Cancer: A Mechanistic Approach.
    Muthusami S; Ramachandran I; Krishnamoorthy S; Sambandam Y; Ramalingam S; Queimado L; Chaudhuri G; Ramachandran IK
    Endocr Metab Immune Disord Drug Targets; 2021; 21(1):67-76. PubMed ID: 32940190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-inflammatory natural product goniothalamin reduces colitis-associated and sporadic colorectal tumorigenesis.
    Vendramini-Costa DB; Francescone R; Posocco D; Hou V; Dmitrieva O; Hensley H; de Carvalho JE; Pilli RA; Grivennikov SI
    Carcinogenesis; 2017 Jan; 38(1):51-63. PubMed ID: 27797827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammation and colorectal cancer.
    Kraus S; Arber N
    Curr Opin Pharmacol; 2009 Aug; 9(4):405-10. PubMed ID: 19589728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
    Pedersen G
    Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal inflammation and colorectal cancer: a double-edged sword?
    Rizzo A; Pallone F; Monteleone G; Fantini MC
    World J Gastroenterol; 2011 Jul; 17(26):3092-100. PubMed ID: 21912451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of JNK2 as carcinogenic factor in colitis-associated and sporadic colorectal carcinogenesis.
    Lessel W; Silver A; Jechorek D; Guenther T; Roehl FW; Kalinski T; Roessner A; Poehlmann-Nitsche A
    Carcinogenesis; 2017 May; 38(5):559-569. PubMed ID: 28383667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigating intestinal inflammation in DSS-induced model of IBD.
    Kim JJ; Shajib MS; Manocha MM; Khan WI
    J Vis Exp; 2012 Feb; (60):. PubMed ID: 22331082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of tumor necrosis factor receptor in the inflammatory bowel disease.
    Souza RF; Caetano MAF; Magalhães HIR; Castelucci P
    World J Gastroenterol; 2023 May; 29(18):2733-2746. PubMed ID: 37274062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel mouse model of inflammatory bowel disease links mammalian target of rapamycin-dependent hyperproliferation of colonic epithelium to inflammation-associated tumorigenesis.
    Deng L; Zhou JF; Sellers RS; Li JF; Nguyen AV; Wang Y; Orlofsky A; Liu Q; Hume DA; Pollard JW; Augenlicht L; Lin EY
    Am J Pathol; 2010 Feb; 176(2):952-67. PubMed ID: 20042677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential dual immunomodulatory role of VEGF in ulcerative colitis and colorectal carcinoma.
    Zdravkovic ND; Jovanovic IP; Radosavljevic GD; Arsenijevic AN; Zdravkovic ND; Mitrovic SLj; Arsenijevic NN
    Int J Med Sci; 2014; 11(9):936-47. PubMed ID: 25076849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pro-inflammatory TNF-α and IFN-γ Promote Tumor Growth and Metastasis via Induction of MACC1.
    Kobelt D; Zhang C; Clayton-Lucey IA; Glauben R; Voss C; Siegmund B; Stein U
    Front Immunol; 2020; 11():980. PubMed ID: 32670264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overview of molecular pathways in inflammatory bowel disease associated with colorectal cancer development.
    Azer SA
    Eur J Gastroenterol Hepatol; 2013 Mar; 25(3):271-81. PubMed ID: 23169309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KFL2 participates in the development of ulcerative colitis through inhibiting inflammation via regulating cytokines.
    Wang ZL; Wang YD; Wang K; Li JA; Li L
    Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4941-4948. PubMed ID: 30070340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokines: from gut inflammation to colorectal cancer.
    Fantini MC; Pallone F
    Curr Drug Targets; 2008 May; 9(5):375-80. PubMed ID: 18473765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epithelial Smad4 Deletion Up-Regulates Inflammation and Promotes Inflammation-Associated Cancer.
    Means AL; Freeman TJ; Zhu J; Woodbury LG; Marincola-Smith P; Wu C; Meyer AR; Weaver CJ; Padmanabhan C; An H; Zi J; Wessinger BC; Chaturvedi R; Brown TD; Deane NG; Coffey RJ; Wilson KT; Smith JJ; Sawyers CL; Goldenring JR; Novitskiy SV; Washington MK; Shi C; Beauchamp RD
    Cell Mol Gastroenterol Hepatol; 2018; 6(3):257-276. PubMed ID: 30109253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokines in colitis associated cancer: potential drug targets?
    Waldner MJ; Neurath MF
    Inflamm Allergy Drug Targets; 2008 Sep; 7(3):187-94. PubMed ID: 18782026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinoid acid induced 16 deficiency aggravates colitis and colitis-associated tumorigenesis in mice.
    Xu YL; Ding CL; Qian CL; Qi ZT; Wang W
    Cell Death Dis; 2019 Dec; 10(12):958. PubMed ID: 31862898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Biomarkers for Inflammatory Bowel Disease and Colorectal Cancer: An Interplay between Metabolic Dysregulation and Excessive Inflammation.
    Salla M; Guo J; Joshi H; Gordon M; Dooky H; Lai J; Capicio S; Armstrong H; Valcheva R; Dyck JRB; Thiesen A; Wine E; Dieleman LA; Baksh S
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36983040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intestinal immunomodulation. Role of regulative peptides and promising pharmacological activities.
    Motilva V; Talero E; Calvo JR; Villegas I; Alarcón-de-la-Lastra C; Sánchez-Fidalgo S
    Curr Pharm Des; 2008; 14(1):71-95. PubMed ID: 18220820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.